Global Dental Anti-inflammatory Drugs Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Dental Anti-inflammatory Drugs market size was valued at US$ 1300 million in 2025 and is forecast to a readjusted size of US$ 1826 million by 2032 with a CAGR of 5.0% during review period.
In 2025, the global production of dental anti-inflammatory drugs reached approximately 115 million units, with an average global market price of around US$11 per unit. In the same year, the global total production capacity of dental anti-inflammatory drugs reached 143 million units. The industry average gross profit margin of this product reached 42%.Dental anti-inflammatory drugs refer to drugs specifically used to prevent or treat oral inflammation, infection and related postoperative symptoms. These drugs are widely used in periodontitis, root canal treatment, post-extraction care and other scenarios by inhibiting bacterial growth, reducing redness, swelling and pain, or promoting mucosal repair.
The upstream segment of the dental anti-inflammatory drug industry chain primarily comprises suppliers of active pharmaceutical ingredients (APIs), plant extracts and other active components, pharmaceutical excipients, packaging materials, and pharmaceutical manufacturing equipment; these involve various raw material categories such as antibiotics, non-steroidal anti-inflammatory drugs (NSAIDs), and local antimicrobial/anti-inflammatory agents. The midstream segment consists mainly of R&D and manufacturing enterprises that handle formulation design, API preparation or procurement, finished product manufacturing, quality control, regulatory filing, and packaging; product forms include tablets, capsules, oral solutions, gels, mouthwashes, sprays, and injections. The downstream segment reaches dental hospitals, dental departments in general hospitals, dental clinics, and the home-use market through channels such as pharmaceutical distributors, hospital pharmacies, retail pharmacies, and e-commerce platforms. These drugs are ultimately used to manage conditions including odontogenic infections, periodontal inflammation, pericoronitis, and oral soft tissue inflammation, as well as to control inflammation and pain following dental surgery. The entire industry chain is collectively influenced by pharmaceutical regulations, clinical medication guidelines, policies on the rational use of antibiotics, and shifting demands for oral healthcare services.
Driven by the aging global population, the persistent burden of dental caries and periodontal disease, the rising volume of dental implants and oral surgeries, and increased public awareness of oral health and dental visit rates, dental anti-inflammatory drugs maintain stable clinical demand. However, the industry's growth logic is shifting from the mere expansion of antibiotic use toward standardized, precision, and localized treatment approaches. Future use of systemic antibiotics will face stricter constraints regarding antimicrobial resistance management and prescribing protocols, while products featuring local administration, targeted release, low systemic exposure, and combined anti-inflammatory and analgesic properties are poised for wider adoption. Concurrently, key R&D directions will focus on local periodontal drug delivery systems, novel antimicrobial materials, sustained- and controlled-release formulations, and products offering combined anti-inflammatory, antimicrobial, and tissue-repair capabilities. Overall, the dental anti-inflammatory drug market is expected to experience moderate growth, with the product mix gradually evolving toward options that offer enhanced safety, stronger local efficacy, greater convenience, and more clearly defined clinical indications.
Global Dental Anti-inflammatory Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Dental Anti-inflammatory Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Dental Anti-inflammatory Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Dental Anti-inflammatory Drugs market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Chapter 2, to profile the top manufacturers of Dental Anti-inflammatory Drugs, with price, sales quantity, revenue, and global market share of Dental Anti-inflammatory Drugs from 2021 to 2026.
Chapter 3, the Dental Anti-inflammatory Drugs competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Dental Anti-inflammatory Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Dental Anti-inflammatory Drugs market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Dental Anti-inflammatory Drugs.
Chapter 14 and 15, to describe Dental Anti-inflammatory Drugs sales channel, distributors, customers, research findings and conclusion.
In 2025, the global production of dental anti-inflammatory drugs reached approximately 115 million units, with an average global market price of around US$11 per unit. In the same year, the global total production capacity of dental anti-inflammatory drugs reached 143 million units. The industry average gross profit margin of this product reached 42%.Dental anti-inflammatory drugs refer to drugs specifically used to prevent or treat oral inflammation, infection and related postoperative symptoms. These drugs are widely used in periodontitis, root canal treatment, post-extraction care and other scenarios by inhibiting bacterial growth, reducing redness, swelling and pain, or promoting mucosal repair.
The upstream segment of the dental anti-inflammatory drug industry chain primarily comprises suppliers of active pharmaceutical ingredients (APIs), plant extracts and other active components, pharmaceutical excipients, packaging materials, and pharmaceutical manufacturing equipment; these involve various raw material categories such as antibiotics, non-steroidal anti-inflammatory drugs (NSAIDs), and local antimicrobial/anti-inflammatory agents. The midstream segment consists mainly of R&D and manufacturing enterprises that handle formulation design, API preparation or procurement, finished product manufacturing, quality control, regulatory filing, and packaging; product forms include tablets, capsules, oral solutions, gels, mouthwashes, sprays, and injections. The downstream segment reaches dental hospitals, dental departments in general hospitals, dental clinics, and the home-use market through channels such as pharmaceutical distributors, hospital pharmacies, retail pharmacies, and e-commerce platforms. These drugs are ultimately used to manage conditions including odontogenic infections, periodontal inflammation, pericoronitis, and oral soft tissue inflammation, as well as to control inflammation and pain following dental surgery. The entire industry chain is collectively influenced by pharmaceutical regulations, clinical medication guidelines, policies on the rational use of antibiotics, and shifting demands for oral healthcare services.
Driven by the aging global population, the persistent burden of dental caries and periodontal disease, the rising volume of dental implants and oral surgeries, and increased public awareness of oral health and dental visit rates, dental anti-inflammatory drugs maintain stable clinical demand. However, the industry's growth logic is shifting from the mere expansion of antibiotic use toward standardized, precision, and localized treatment approaches. Future use of systemic antibiotics will face stricter constraints regarding antimicrobial resistance management and prescribing protocols, while products featuring local administration, targeted release, low systemic exposure, and combined anti-inflammatory and analgesic properties are poised for wider adoption. Concurrently, key R&D directions will focus on local periodontal drug delivery systems, novel antimicrobial materials, sustained- and controlled-release formulations, and products offering combined anti-inflammatory, antimicrobial, and tissue-repair capabilities. Overall, the dental anti-inflammatory drug market is expected to experience moderate growth, with the product mix gradually evolving toward options that offer enhanced safety, stronger local efficacy, greater convenience, and more clearly defined clinical indications.
Report Scope
This report is a detailed and comprehensive analysis for global Dental Anti-inflammatory Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.Key Features:
Global Dental Anti-inflammatory Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032Global Dental Anti-inflammatory Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Dental Anti-inflammatory Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Dental Anti-inflammatory Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for Dental Anti-inflammatory Drugs
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Dental Anti-inflammatory Drugs market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market Segmentation
Market segment by Type
- Oral Rinse
- Oral Gel/Ointment
- Oral Spray
- Oral Tablets
- Oral Powder
- Others
Market segment by Number of Active Ingredients
- Single-Active-Ingredient Type (1 Active Ingredient)
- Multi-Active-Ingredient Type (≥2 Active Ingredients)
Market segment by Pharmacological Action
- Antimicrobial
- Anti-inflammatory
- Combined Antimicrobial and Anti-inflammatory
- Tissue Repair
- Others
Market segment by Application
- Online Sales (Pharmaceutical E-Commerce Platforms, Online Hospital Marketplaces, Official Brand Stores, etc.)
- Hospitals (Dental Departments In General Hospitals, Specialized Dental Hospitals, Pediatric Dental Departments, etc.)
- Pharmacies (Chain Retail Pharmacies, Community Pharmacies, etc.)
- Clinics (Independent Dental Clinics, Dental Clinic Chains, etc.)
- Others
Major players covered
- Haleon
- Taro Pharmaceuticals
- iNova Pharmaceuticals
- Lion Corporation
- Sato Pharmaceutical
- Daiichi Sankyo Healthcare
- Rohto Pharmaceutical
- Kobayashi Pharmaceutical
- Kowa Company
- Guilin Sanjin Pharmaceutical
- ICPA Health Products
- VistaPharm, Inc.
- Patterson Dental Supply, Inc.
Market segment by region, regional analysis covers
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter Outline
Chapter 1, to describe Dental Anti-inflammatory Drugs product scope, market overview, market estimation caveats and base year.Chapter 2, to profile the top manufacturers of Dental Anti-inflammatory Drugs, with price, sales quantity, revenue, and global market share of Dental Anti-inflammatory Drugs from 2021 to 2026.
Chapter 3, the Dental Anti-inflammatory Drugs competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Dental Anti-inflammatory Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Dental Anti-inflammatory Drugs market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Dental Anti-inflammatory Drugs.
Chapter 14 and 15, to describe Dental Anti-inflammatory Drugs sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Dental Anti-inflammatory Drugs Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Oral Rinse
1.3.3 Oral Gel/Ointment
1.3.4 Oral Spray
1.3.5 Oral Tablets
1.3.6 Oral Powder
1.3.7 Others
1.4 Market Analysis by Number of Active Ingredients
1.4.1 Overview: Global Dental Anti-inflammatory Drugs Consumption Value by Number of Active Ingredients: 2021 Versus 2025 Versus 2032
1.4.2 Single-Active-Ingredient Type (1 Active Ingredient)
1.4.3 Multi-Active-Ingredient Type (≥2 Active Ingredients)
1.5 Market Analysis by Pharmacological Action
1.5.1 Overview: Global Dental Anti-inflammatory Drugs Consumption Value by Pharmacological Action: 2021 Versus 2025 Versus 2032
1.5.2 Antimicrobial
1.5.3 Anti-inflammatory
1.5.4 Combined Antimicrobial and Anti-inflammatory
1.5.5 Tissue Repair
1.5.6 Others
1.6 Market Analysis by Application
1.6.1 Overview: Global Dental Anti-inflammatory Drugs Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.6.2 Online Sales (Pharmaceutical E-Commerce Platforms, Online Hospital Marketplaces, Official Brand Stores, etc.)
1.6.3 Hospitals (Dental Departments In General Hospitals, Specialized Dental Hospitals, Pediatric Dental Departments, etc.)
1.6.4 Pharmacies (Chain Retail Pharmacies, Community Pharmacies, etc.)
1.6.5 Clinics (Independent Dental Clinics, Dental Clinic Chains, etc.)
1.6.6 Others
1.7 Global Dental Anti-inflammatory Drugs Market Size & Forecast
1.7.1 Global Dental Anti-inflammatory Drugs Consumption Value (2021 & 2025 & 2032)
1.7.2 Global Dental Anti-inflammatory Drugs Sales Quantity (2021-2032)
1.7.3 Global Dental Anti-inflammatory Drugs Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Haleon
2.1.1 Haleon Details
2.1.2 Haleon Major Business
2.1.3 Haleon Dental Anti-inflammatory Drugs Product and Services
2.1.4 Haleon Dental Anti-inflammatory Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Haleon Recent Developments/Updates
2.2 Taro Pharmaceuticals
2.2.1 Taro Pharmaceuticals Details
2.2.2 Taro Pharmaceuticals Major Business
2.2.3 Taro Pharmaceuticals Dental Anti-inflammatory Drugs Product and Services
2.2.4 Taro Pharmaceuticals Dental Anti-inflammatory Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Taro Pharmaceuticals Recent Developments/Updates
2.3 iNova Pharmaceuticals
2.3.1 iNova Pharmaceuticals Details
2.3.2 iNova Pharmaceuticals Major Business
2.3.3 iNova Pharmaceuticals Dental Anti-inflammatory Drugs Product and Services
2.3.4 iNova Pharmaceuticals Dental Anti-inflammatory Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 iNova Pharmaceuticals Recent Developments/Updates
2.4 Lion Corporation
2.4.1 Lion Corporation Details
2.4.2 Lion Corporation Major Business
2.4.3 Lion Corporation Dental Anti-inflammatory Drugs Product and Services
2.4.4 Lion Corporation Dental Anti-inflammatory Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Lion Corporation Recent Developments/Updates
2.5 Sato Pharmaceutical
2.5.1 Sato Pharmaceutical Details
2.5.2 Sato Pharmaceutical Major Business
2.5.3 Sato Pharmaceutical Dental Anti-inflammatory Drugs Product and Services
2.5.4 Sato Pharmaceutical Dental Anti-inflammatory Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Sato Pharmaceutical Recent Developments/Updates
2.6 Daiichi Sankyo Healthcare
2.6.1 Daiichi Sankyo Healthcare Details
2.6.2 Daiichi Sankyo Healthcare Major Business
2.6.3 Daiichi Sankyo Healthcare Dental Anti-inflammatory Drugs Product and Services
2.6.4 Daiichi Sankyo Healthcare Dental Anti-inflammatory Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Daiichi Sankyo Healthcare Recent Developments/Updates
2.7 Rohto Pharmaceutical
2.7.1 Rohto Pharmaceutical Details
2.7.2 Rohto Pharmaceutical Major Business
2.7.3 Rohto Pharmaceutical Dental Anti-inflammatory Drugs Product and Services
2.7.4 Rohto Pharmaceutical Dental Anti-inflammatory Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Rohto Pharmaceutical Recent Developments/Updates
2.8 Kobayashi Pharmaceutical
2.8.1 Kobayashi Pharmaceutical Details
2.8.2 Kobayashi Pharmaceutical Major Business
2.8.3 Kobayashi Pharmaceutical Dental Anti-inflammatory Drugs Product and Services
2.8.4 Kobayashi Pharmaceutical Dental Anti-inflammatory Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Kobayashi Pharmaceutical Recent Developments/Updates
2.9 Kowa Company
2.9.1 Kowa Company Details
2.9.2 Kowa Company Major Business
2.9.3 Kowa Company Dental Anti-inflammatory Drugs Product and Services
2.9.4 Kowa Company Dental Anti-inflammatory Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Kowa Company Recent Developments/Updates
2.10 Guilin Sanjin Pharmaceutical
2.10.1 Guilin Sanjin Pharmaceutical Details
2.10.2 Guilin Sanjin Pharmaceutical Major Business
2.10.3 Guilin Sanjin Pharmaceutical Dental Anti-inflammatory Drugs Product and Services
2.10.4 Guilin Sanjin Pharmaceutical Dental Anti-inflammatory Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Guilin Sanjin Pharmaceutical Recent Developments/Updates
2.11 ICPA Health Products
2.11.1 ICPA Health Products Details
2.11.2 ICPA Health Products Major Business
2.11.3 ICPA Health Products Dental Anti-inflammatory Drugs Product and Services
2.11.4 ICPA Health Products Dental Anti-inflammatory Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 ICPA Health Products Recent Developments/Updates
2.12 VistaPharm, Inc.
2.12.1 VistaPharm, Inc. Details
2.12.2 VistaPharm, Inc. Major Business
2.12.3 VistaPharm, Inc. Dental Anti-inflammatory Drugs Product and Services
2.12.4 VistaPharm, Inc. Dental Anti-inflammatory Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 VistaPharm, Inc. Recent Developments/Updates
2.13 Patterson Dental Supply, Inc.
2.13.1 Patterson Dental Supply, Inc. Details
2.13.2 Patterson Dental Supply, Inc. Major Business
2.13.3 Patterson Dental Supply, Inc. Dental Anti-inflammatory Drugs Product and Services
2.13.4 Patterson Dental Supply, Inc. Dental Anti-inflammatory Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Patterson Dental Supply, Inc. Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: DENTAL ANTI-INFLAMMATORY DRUGS BY MANUFACTURER
3.1 Global Dental Anti-inflammatory Drugs Sales Quantity by Manufacturer (2021-2026)
3.2 Global Dental Anti-inflammatory Drugs Revenue by Manufacturer (2021-2026)
3.3 Global Dental Anti-inflammatory Drugs Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Dental Anti-inflammatory Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Dental Anti-inflammatory Drugs Manufacturer Market Share in 2025
3.4.3 Top 6 Dental Anti-inflammatory Drugs Manufacturer Market Share in 2025
3.5 Dental Anti-inflammatory Drugs Market: Overall Company Footprint Analysis
3.5.1 Dental Anti-inflammatory Drugs Market: Region Footprint
3.5.2 Dental Anti-inflammatory Drugs Market: Company Product Type Footprint
3.5.3 Dental Anti-inflammatory Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Dental Anti-inflammatory Drugs Market Size by Region
4.1.1 Global Dental Anti-inflammatory Drugs Sales Quantity by Region (2021-2032)
4.1.2 Global Dental Anti-inflammatory Drugs Consumption Value by Region (2021-2032)
4.1.3 Global Dental Anti-inflammatory Drugs Average Price by Region (2021-2032)
4.2 North America Dental Anti-inflammatory Drugs Consumption Value (2021-2032)
4.3 Europe Dental Anti-inflammatory Drugs Consumption Value (2021-2032)
4.4 Asia-Pacific Dental Anti-inflammatory Drugs Consumption Value (2021-2032)
4.5 South America Dental Anti-inflammatory Drugs Consumption Value (2021-2032)
4.6 Middle East & Africa Dental Anti-inflammatory Drugs Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Dental Anti-inflammatory Drugs Sales Quantity by Type (2021-2032)
5.2 Global Dental Anti-inflammatory Drugs Consumption Value by Type (2021-2032)
5.3 Global Dental Anti-inflammatory Drugs Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Dental Anti-inflammatory Drugs Sales Quantity by Application (2021-2032)
6.2 Global Dental Anti-inflammatory Drugs Consumption Value by Application (2021-2032)
6.3 Global Dental Anti-inflammatory Drugs Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Dental Anti-inflammatory Drugs Sales Quantity by Type (2021-2032)
7.2 North America Dental Anti-inflammatory Drugs Sales Quantity by Application (2021-2032)
7.3 North America Dental Anti-inflammatory Drugs Market Size by Country
7.3.1 North America Dental Anti-inflammatory Drugs Sales Quantity by Country (2021-2032)
7.3.2 North America Dental Anti-inflammatory Drugs Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Dental Anti-inflammatory Drugs Sales Quantity by Type (2021-2032)
8.2 Europe Dental Anti-inflammatory Drugs Sales Quantity by Application (2021-2032)
8.3 Europe Dental Anti-inflammatory Drugs Market Size by Country
8.3.1 Europe Dental Anti-inflammatory Drugs Sales Quantity by Country (2021-2032)
8.3.2 Europe Dental Anti-inflammatory Drugs Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Dental Anti-inflammatory Drugs Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Dental Anti-inflammatory Drugs Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Dental Anti-inflammatory Drugs Market Size by Region
9.3.1 Asia-Pacific Dental Anti-inflammatory Drugs Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Dental Anti-inflammatory Drugs Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Dental Anti-inflammatory Drugs Sales Quantity by Type (2021-2032)
10.2 South America Dental Anti-inflammatory Drugs Sales Quantity by Application (2021-2032)
10.3 South America Dental Anti-inflammatory Drugs Market Size by Country
10.3.1 South America Dental Anti-inflammatory Drugs Sales Quantity by Country (2021-2032)
10.3.2 South America Dental Anti-inflammatory Drugs Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Dental Anti-inflammatory Drugs Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Dental Anti-inflammatory Drugs Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Dental Anti-inflammatory Drugs Market Size by Country
11.3.1 Middle East & Africa Dental Anti-inflammatory Drugs Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Dental Anti-inflammatory Drugs Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Dental Anti-inflammatory Drugs Market Drivers
12.2 Dental Anti-inflammatory Drugs Market Restraints
12.3 Dental Anti-inflammatory Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Dental Anti-inflammatory Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Dental Anti-inflammatory Drugs
13.3 Dental Anti-inflammatory Drugs Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Dental Anti-inflammatory Drugs Typical Distributors
14.3 Dental Anti-inflammatory Drugs Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Dental Anti-inflammatory Drugs Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Oral Rinse
1.3.3 Oral Gel/Ointment
1.3.4 Oral Spray
1.3.5 Oral Tablets
1.3.6 Oral Powder
1.3.7 Others
1.4 Market Analysis by Number of Active Ingredients
1.4.1 Overview: Global Dental Anti-inflammatory Drugs Consumption Value by Number of Active Ingredients: 2021 Versus 2025 Versus 2032
1.4.2 Single-Active-Ingredient Type (1 Active Ingredient)
1.4.3 Multi-Active-Ingredient Type (≥2 Active Ingredients)
1.5 Market Analysis by Pharmacological Action
1.5.1 Overview: Global Dental Anti-inflammatory Drugs Consumption Value by Pharmacological Action: 2021 Versus 2025 Versus 2032
1.5.2 Antimicrobial
1.5.3 Anti-inflammatory
1.5.4 Combined Antimicrobial and Anti-inflammatory
1.5.5 Tissue Repair
1.5.6 Others
1.6 Market Analysis by Application
1.6.1 Overview: Global Dental Anti-inflammatory Drugs Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.6.2 Online Sales (Pharmaceutical E-Commerce Platforms, Online Hospital Marketplaces, Official Brand Stores, etc.)
1.6.3 Hospitals (Dental Departments In General Hospitals, Specialized Dental Hospitals, Pediatric Dental Departments, etc.)
1.6.4 Pharmacies (Chain Retail Pharmacies, Community Pharmacies, etc.)
1.6.5 Clinics (Independent Dental Clinics, Dental Clinic Chains, etc.)
1.6.6 Others
1.7 Global Dental Anti-inflammatory Drugs Market Size & Forecast
1.7.1 Global Dental Anti-inflammatory Drugs Consumption Value (2021 & 2025 & 2032)
1.7.2 Global Dental Anti-inflammatory Drugs Sales Quantity (2021-2032)
1.7.3 Global Dental Anti-inflammatory Drugs Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Haleon
2.1.1 Haleon Details
2.1.2 Haleon Major Business
2.1.3 Haleon Dental Anti-inflammatory Drugs Product and Services
2.1.4 Haleon Dental Anti-inflammatory Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Haleon Recent Developments/Updates
2.2 Taro Pharmaceuticals
2.2.1 Taro Pharmaceuticals Details
2.2.2 Taro Pharmaceuticals Major Business
2.2.3 Taro Pharmaceuticals Dental Anti-inflammatory Drugs Product and Services
2.2.4 Taro Pharmaceuticals Dental Anti-inflammatory Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Taro Pharmaceuticals Recent Developments/Updates
2.3 iNova Pharmaceuticals
2.3.1 iNova Pharmaceuticals Details
2.3.2 iNova Pharmaceuticals Major Business
2.3.3 iNova Pharmaceuticals Dental Anti-inflammatory Drugs Product and Services
2.3.4 iNova Pharmaceuticals Dental Anti-inflammatory Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 iNova Pharmaceuticals Recent Developments/Updates
2.4 Lion Corporation
2.4.1 Lion Corporation Details
2.4.2 Lion Corporation Major Business
2.4.3 Lion Corporation Dental Anti-inflammatory Drugs Product and Services
2.4.4 Lion Corporation Dental Anti-inflammatory Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Lion Corporation Recent Developments/Updates
2.5 Sato Pharmaceutical
2.5.1 Sato Pharmaceutical Details
2.5.2 Sato Pharmaceutical Major Business
2.5.3 Sato Pharmaceutical Dental Anti-inflammatory Drugs Product and Services
2.5.4 Sato Pharmaceutical Dental Anti-inflammatory Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Sato Pharmaceutical Recent Developments/Updates
2.6 Daiichi Sankyo Healthcare
2.6.1 Daiichi Sankyo Healthcare Details
2.6.2 Daiichi Sankyo Healthcare Major Business
2.6.3 Daiichi Sankyo Healthcare Dental Anti-inflammatory Drugs Product and Services
2.6.4 Daiichi Sankyo Healthcare Dental Anti-inflammatory Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Daiichi Sankyo Healthcare Recent Developments/Updates
2.7 Rohto Pharmaceutical
2.7.1 Rohto Pharmaceutical Details
2.7.2 Rohto Pharmaceutical Major Business
2.7.3 Rohto Pharmaceutical Dental Anti-inflammatory Drugs Product and Services
2.7.4 Rohto Pharmaceutical Dental Anti-inflammatory Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Rohto Pharmaceutical Recent Developments/Updates
2.8 Kobayashi Pharmaceutical
2.8.1 Kobayashi Pharmaceutical Details
2.8.2 Kobayashi Pharmaceutical Major Business
2.8.3 Kobayashi Pharmaceutical Dental Anti-inflammatory Drugs Product and Services
2.8.4 Kobayashi Pharmaceutical Dental Anti-inflammatory Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Kobayashi Pharmaceutical Recent Developments/Updates
2.9 Kowa Company
2.9.1 Kowa Company Details
2.9.2 Kowa Company Major Business
2.9.3 Kowa Company Dental Anti-inflammatory Drugs Product and Services
2.9.4 Kowa Company Dental Anti-inflammatory Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Kowa Company Recent Developments/Updates
2.10 Guilin Sanjin Pharmaceutical
2.10.1 Guilin Sanjin Pharmaceutical Details
2.10.2 Guilin Sanjin Pharmaceutical Major Business
2.10.3 Guilin Sanjin Pharmaceutical Dental Anti-inflammatory Drugs Product and Services
2.10.4 Guilin Sanjin Pharmaceutical Dental Anti-inflammatory Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Guilin Sanjin Pharmaceutical Recent Developments/Updates
2.11 ICPA Health Products
2.11.1 ICPA Health Products Details
2.11.2 ICPA Health Products Major Business
2.11.3 ICPA Health Products Dental Anti-inflammatory Drugs Product and Services
2.11.4 ICPA Health Products Dental Anti-inflammatory Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 ICPA Health Products Recent Developments/Updates
2.12 VistaPharm, Inc.
2.12.1 VistaPharm, Inc. Details
2.12.2 VistaPharm, Inc. Major Business
2.12.3 VistaPharm, Inc. Dental Anti-inflammatory Drugs Product and Services
2.12.4 VistaPharm, Inc. Dental Anti-inflammatory Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 VistaPharm, Inc. Recent Developments/Updates
2.13 Patterson Dental Supply, Inc.
2.13.1 Patterson Dental Supply, Inc. Details
2.13.2 Patterson Dental Supply, Inc. Major Business
2.13.3 Patterson Dental Supply, Inc. Dental Anti-inflammatory Drugs Product and Services
2.13.4 Patterson Dental Supply, Inc. Dental Anti-inflammatory Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Patterson Dental Supply, Inc. Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: DENTAL ANTI-INFLAMMATORY DRUGS BY MANUFACTURER
3.1 Global Dental Anti-inflammatory Drugs Sales Quantity by Manufacturer (2021-2026)
3.2 Global Dental Anti-inflammatory Drugs Revenue by Manufacturer (2021-2026)
3.3 Global Dental Anti-inflammatory Drugs Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Dental Anti-inflammatory Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Dental Anti-inflammatory Drugs Manufacturer Market Share in 2025
3.4.3 Top 6 Dental Anti-inflammatory Drugs Manufacturer Market Share in 2025
3.5 Dental Anti-inflammatory Drugs Market: Overall Company Footprint Analysis
3.5.1 Dental Anti-inflammatory Drugs Market: Region Footprint
3.5.2 Dental Anti-inflammatory Drugs Market: Company Product Type Footprint
3.5.3 Dental Anti-inflammatory Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Dental Anti-inflammatory Drugs Market Size by Region
4.1.1 Global Dental Anti-inflammatory Drugs Sales Quantity by Region (2021-2032)
4.1.2 Global Dental Anti-inflammatory Drugs Consumption Value by Region (2021-2032)
4.1.3 Global Dental Anti-inflammatory Drugs Average Price by Region (2021-2032)
4.2 North America Dental Anti-inflammatory Drugs Consumption Value (2021-2032)
4.3 Europe Dental Anti-inflammatory Drugs Consumption Value (2021-2032)
4.4 Asia-Pacific Dental Anti-inflammatory Drugs Consumption Value (2021-2032)
4.5 South America Dental Anti-inflammatory Drugs Consumption Value (2021-2032)
4.6 Middle East & Africa Dental Anti-inflammatory Drugs Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Dental Anti-inflammatory Drugs Sales Quantity by Type (2021-2032)
5.2 Global Dental Anti-inflammatory Drugs Consumption Value by Type (2021-2032)
5.3 Global Dental Anti-inflammatory Drugs Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Dental Anti-inflammatory Drugs Sales Quantity by Application (2021-2032)
6.2 Global Dental Anti-inflammatory Drugs Consumption Value by Application (2021-2032)
6.3 Global Dental Anti-inflammatory Drugs Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Dental Anti-inflammatory Drugs Sales Quantity by Type (2021-2032)
7.2 North America Dental Anti-inflammatory Drugs Sales Quantity by Application (2021-2032)
7.3 North America Dental Anti-inflammatory Drugs Market Size by Country
7.3.1 North America Dental Anti-inflammatory Drugs Sales Quantity by Country (2021-2032)
7.3.2 North America Dental Anti-inflammatory Drugs Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Dental Anti-inflammatory Drugs Sales Quantity by Type (2021-2032)
8.2 Europe Dental Anti-inflammatory Drugs Sales Quantity by Application (2021-2032)
8.3 Europe Dental Anti-inflammatory Drugs Market Size by Country
8.3.1 Europe Dental Anti-inflammatory Drugs Sales Quantity by Country (2021-2032)
8.3.2 Europe Dental Anti-inflammatory Drugs Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Dental Anti-inflammatory Drugs Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Dental Anti-inflammatory Drugs Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Dental Anti-inflammatory Drugs Market Size by Region
9.3.1 Asia-Pacific Dental Anti-inflammatory Drugs Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Dental Anti-inflammatory Drugs Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Dental Anti-inflammatory Drugs Sales Quantity by Type (2021-2032)
10.2 South America Dental Anti-inflammatory Drugs Sales Quantity by Application (2021-2032)
10.3 South America Dental Anti-inflammatory Drugs Market Size by Country
10.3.1 South America Dental Anti-inflammatory Drugs Sales Quantity by Country (2021-2032)
10.3.2 South America Dental Anti-inflammatory Drugs Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Dental Anti-inflammatory Drugs Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Dental Anti-inflammatory Drugs Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Dental Anti-inflammatory Drugs Market Size by Country
11.3.1 Middle East & Africa Dental Anti-inflammatory Drugs Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Dental Anti-inflammatory Drugs Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Dental Anti-inflammatory Drugs Market Drivers
12.2 Dental Anti-inflammatory Drugs Market Restraints
12.3 Dental Anti-inflammatory Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Dental Anti-inflammatory Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Dental Anti-inflammatory Drugs
13.3 Dental Anti-inflammatory Drugs Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Dental Anti-inflammatory Drugs Typical Distributors
14.3 Dental Anti-inflammatory Drugs Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Dental Anti-inflammatory Drugs Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Dental Anti-inflammatory Drugs Consumption Value by Number of Active Ingredients, (USD Million), 2021 & 2025 & 2032
Table 3. Global Dental Anti-inflammatory Drugs Consumption Value by Pharmacological Action, (USD Million), 2021 & 2025 & 2032
Table 4. Global Dental Anti-inflammatory Drugs Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Haleon Basic Information, Manufacturing Base and Competitors
Table 6. Haleon Major Business
Table 7. Haleon Dental Anti-inflammatory Drugs Product and Services
Table 8. Haleon Dental Anti-inflammatory Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. Haleon Recent Developments/Updates
Table 10. Taro Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 11. Taro Pharmaceuticals Major Business
Table 12. Taro Pharmaceuticals Dental Anti-inflammatory Drugs Product and Services
Table 13. Taro Pharmaceuticals Dental Anti-inflammatory Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. Taro Pharmaceuticals Recent Developments/Updates
Table 15. iNova Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 16. iNova Pharmaceuticals Major Business
Table 17. iNova Pharmaceuticals Dental Anti-inflammatory Drugs Product and Services
Table 18. iNova Pharmaceuticals Dental Anti-inflammatory Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. iNova Pharmaceuticals Recent Developments/Updates
Table 20. Lion Corporation Basic Information, Manufacturing Base and Competitors
Table 21. Lion Corporation Major Business
Table 22. Lion Corporation Dental Anti-inflammatory Drugs Product and Services
Table 23. Lion Corporation Dental Anti-inflammatory Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 24. Lion Corporation Recent Developments/Updates
Table 25. Sato Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 26. Sato Pharmaceutical Major Business
Table 27. Sato Pharmaceutical Dental Anti-inflammatory Drugs Product and Services
Table 28. Sato Pharmaceutical Dental Anti-inflammatory Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 29. Sato Pharmaceutical Recent Developments/Updates
Table 30. Daiichi Sankyo Healthcare Basic Information, Manufacturing Base and Competitors
Table 31. Daiichi Sankyo Healthcare Major Business
Table 32. Daiichi Sankyo Healthcare Dental Anti-inflammatory Drugs Product and Services
Table 33. Daiichi Sankyo Healthcare Dental Anti-inflammatory Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 34. Daiichi Sankyo Healthcare Recent Developments/Updates
Table 35. Rohto Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 36. Rohto Pharmaceutical Major Business
Table 37. Rohto Pharmaceutical Dental Anti-inflammatory Drugs Product and Services
Table 38. Rohto Pharmaceutical Dental Anti-inflammatory Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 39. Rohto Pharmaceutical Recent Developments/Updates
Table 40. Kobayashi Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 41. Kobayashi Pharmaceutical Major Business
Table 42. Kobayashi Pharmaceutical Dental Anti-inflammatory Drugs Product and Services
Table 43. Kobayashi Pharmaceutical Dental Anti-inflammatory Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 44. Kobayashi Pharmaceutical Recent Developments/Updates
Table 45. Kowa Company Basic Information, Manufacturing Base and Competitors
Table 46. Kowa Company Major Business
Table 47. Kowa Company Dental Anti-inflammatory Drugs Product and Services
Table 48. Kowa Company Dental Anti-inflammatory Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 49. Kowa Company Recent Developments/Updates
Table 50. Guilin Sanjin Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 51. Guilin Sanjin Pharmaceutical Major Business
Table 52. Guilin Sanjin Pharmaceutical Dental Anti-inflammatory Drugs Product and Services
Table 53. Guilin Sanjin Pharmaceutical Dental Anti-inflammatory Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 54. Guilin Sanjin Pharmaceutical Recent Developments/Updates
Table 55. ICPA Health Products Basic Information, Manufacturing Base and Competitors
Table 56. ICPA Health Products Major Business
Table 57. ICPA Health Products Dental Anti-inflammatory Drugs Product and Services
Table 58. ICPA Health Products Dental Anti-inflammatory Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 59. ICPA Health Products Recent Developments/Updates
Table 60. VistaPharm, Inc. Basic Information, Manufacturing Base and Competitors
Table 61. VistaPharm, Inc. Major Business
Table 62. VistaPharm, Inc. Dental Anti-inflammatory Drugs Product and Services
Table 63. VistaPharm, Inc. Dental Anti-inflammatory Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 64. VistaPharm, Inc. Recent Developments/Updates
Table 65. Patterson Dental Supply, Inc. Basic Information, Manufacturing Base and Competitors
Table 66. Patterson Dental Supply, Inc. Major Business
Table 67. Patterson Dental Supply, Inc. Dental Anti-inflammatory Drugs Product and Services
Table 68. Patterson Dental Supply, Inc. Dental Anti-inflammatory Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 69. Patterson Dental Supply, Inc. Recent Developments/Updates
Table 70. Global Dental Anti-inflammatory Drugs Sales Quantity by Manufacturer (2021-2026) & (K Units)
Table 71. Global Dental Anti-inflammatory Drugs Revenue by Manufacturer (2021-2026) & (USD Million)
Table 72. Global Dental Anti-inflammatory Drugs Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 73. Market Position of Manufacturers in Dental Anti-inflammatory Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 74. Head Office and Dental Anti-inflammatory Drugs Production Site of Key Manufacturer
Table 75. Dental Anti-inflammatory Drugs Market: Company Product Type Footprint
Table 76. Dental Anti-inflammatory Drugs Market: Company Product Application Footprint
Table 77. Dental Anti-inflammatory Drugs New Market Entrants and Barriers to Market Entry
Table 78. Dental Anti-inflammatory Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 79. Global Dental Anti-inflammatory Drugs Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 80. Global Dental Anti-inflammatory Drugs Sales Quantity by Region (2021-2026) & (K Units)
Table 81. Global Dental Anti-inflammatory Drugs Sales Quantity by Region (2027-2032) & (K Units)
Table 82. Global Dental Anti-inflammatory Drugs Consumption Value by Region (2021-2026) & (USD Million)
Table 83. Global Dental Anti-inflammatory Drugs Consumption Value by Region (2027-2032) & (USD Million)
Table 84. Global Dental Anti-inflammatory Drugs Average Price by Region (2021-2026) & (US$/Unit)
Table 85. Global Dental Anti-inflammatory Drugs Average Price by Region (2027-2032) & (US$/Unit)
Table 86. Global Dental Anti-inflammatory Drugs Sales Quantity by Type (2021-2026) & (K Units)
Table 87. Global Dental Anti-inflammatory Drugs Sales Quantity by Type (2027-2032) & (K Units)
Table 88. Global Dental Anti-inflammatory Drugs Consumption Value by Type (2021-2026) & (USD Million)
Table 89. Global Dental Anti-inflammatory Drugs Consumption Value by Type (2027-2032) & (USD Million)
Table 90. Global Dental Anti-inflammatory Drugs Average Price by Type (2021-2026) & (US$/Unit)
Table 91. Global Dental Anti-inflammatory Drugs Average Price by Type (2027-2032) & (US$/Unit)
Table 92. Global Dental Anti-inflammatory Drugs Sales Quantity by Application (2021-2026) & (K Units)
Table 93. Global Dental Anti-inflammatory Drugs Sales Quantity by Application (2027-2032) & (K Units)
Table 94. Global Dental Anti-inflammatory Drugs Consumption Value by Application (2021-2026) & (USD Million)
Table 95. Global Dental Anti-inflammatory Drugs Consumption Value by Application (2027-2032) & (USD Million)
Table 96. Global Dental Anti-inflammatory Drugs Average Price by Application (2021-2026) & (US$/Unit)
Table 97. Global Dental Anti-inflammatory Drugs Average Price by Application (2027-2032) & (US$/Unit)
Table 98. North America Dental Anti-inflammatory Drugs Sales Quantity by Type (2021-2026) & (K Units)
Table 99. North America Dental Anti-inflammatory Drugs Sales Quantity by Type (2027-2032) & (K Units)
Table 100. North America Dental Anti-inflammatory Drugs Sales Quantity by Application (2021-2026) & (K Units)
Table 101. North America Dental Anti-inflammatory Drugs Sales Quantity by Application (2027-2032) & (K Units)
Table 102. North America Dental Anti-inflammatory Drugs Sales Quantity by Country (2021-2026) & (K Units)
Table 103. North America Dental Anti-inflammatory Drugs Sales Quantity by Country (2027-2032) & (K Units)
Table 104. North America Dental Anti-inflammatory Drugs Consumption Value by Country (2021-2026) & (USD Million)
Table 105. North America Dental Anti-inflammatory Drugs Consumption Value by Country (2027-2032) & (USD Million)
Table 106. Europe Dental Anti-inflammatory Drugs Sales Quantity by Type (2021-2026) & (K Units)
Table 107. Europe Dental Anti-inflammatory Drugs Sales Quantity by Type (2027-2032) & (K Units)
Table 108. Europe Dental Anti-inflammatory Drugs Sales Quantity by Application (2021-2026) & (K Units)
Table 109. Europe Dental Anti-inflammatory Drugs Sales Quantity by Application (2027-2032) & (K Units)
Table 110. Europe Dental Anti-inflammatory Drugs Sales Quantity by Country (2021-2026) & (K Units)
Table 111. Europe Dental Anti-inflammatory Drugs Sales Quantity by Country (2027-2032) & (K Units)
Table 112. Europe Dental Anti-inflammatory Drugs Consumption Value by Country (2021-2026) & (USD Million)
Table 113. Europe Dental Anti-inflammatory Drugs Consumption Value by Country (2027-2032) & (USD Million)
Table 114. Asia-Pacific Dental Anti-inflammatory Drugs Sales Quantity by Type (2021-2026) & (K Units)
Table 115. Asia-Pacific Dental Anti-inflammatory Drugs Sales Quantity by Type (2027-2032) & (K Units)
Table 116. Asia-Pacific Dental Anti-inflammatory Drugs Sales Quantity by Application (2021-2026) & (K Units)
Table 117. Asia-Pacific Dental Anti-inflammatory Drugs Sales Quantity by Application (2027-2032) & (K Units)
Table 118. Asia-Pacific Dental Anti-inflammatory Drugs Sales Quantity by Region (2021-2026) & (K Units)
Table 119. Asia-Pacific Dental Anti-inflammatory Drugs Sales Quantity by Region (2027-2032) & (K Units)
Table 120. Asia-Pacific Dental Anti-inflammatory Drugs Consumption Value by Region (2021-2026) & (USD Million)
Table 121. Asia-Pacific Dental Anti-inflammatory Drugs Consumption Value by Region (2027-2032) & (USD Million)
Table 122. South America Dental Anti-inflammatory Drugs Sales Quantity by Type (2021-2026) & (K Units)
Table 123. South America Dental Anti-inflammatory Drugs Sales Quantity by Type (2027-2032) & (K Units)
Table 124. South America Dental Anti-inflammatory Drugs Sales Quantity by Application (2021-2026) & (K Units)
Table 125. South America Dental Anti-inflammatory Drugs Sales Quantity by Application (2027-2032) & (K Units)
Table 126. South America Dental Anti-inflammatory Drugs Sales Quantity by Country (2021-2026) & (K Units)
Table 127. South America Dental Anti-inflammatory Drugs Sales Quantity by Country (2027-2032) & (K Units)
Table 128. South America Dental Anti-inflammatory Drugs Consumption Value by Country (2021-2026) & (USD Million)
Table 129. South America Dental Anti-inflammatory Drugs Consumption Value by Country (2027-2032) & (USD Million)
Table 130. Middle East & Africa Dental Anti-inflammatory Drugs Sales Quantity by Type (2021-2026) & (K Units)
Table 131. Middle East & Africa Dental Anti-inflammatory Drugs Sales Quantity by Type (2027-2032) & (K Units)
Table 132. Middle East & Africa Dental Anti-inflammatory Drugs Sales Quantity by Application (2021-2026) & (K Units)
Table 133. Middle East & Africa Dental Anti-inflammatory Drugs Sales Quantity by Application (2027-2032) & (K Units)
Table 134. Middle East & Africa Dental Anti-inflammatory Drugs Sales Quantity by Country (2021-2026) & (K Units)
Table 135. Middle East & Africa Dental Anti-inflammatory Drugs Sales Quantity by Country (2027-2032) & (K Units)
Table 136. Middle East & Africa Dental Anti-inflammatory Drugs Consumption Value by Country (2021-2026) & (USD Million)
Table 137. Middle East & Africa Dental Anti-inflammatory Drugs Consumption Value by Country (2027-2032) & (USD Million)
Table 138. Dental Anti-inflammatory Drugs Raw Material
Table 139. Key Manufacturers of Dental Anti-inflammatory Drugs Raw Materials
Table 140. Dental Anti-inflammatory Drugs Typical Distributors
Table 141. Dental Anti-inflammatory Drugs Typical Customers
Table 1. Global Dental Anti-inflammatory Drugs Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Dental Anti-inflammatory Drugs Consumption Value by Number of Active Ingredients, (USD Million), 2021 & 2025 & 2032
Table 3. Global Dental Anti-inflammatory Drugs Consumption Value by Pharmacological Action, (USD Million), 2021 & 2025 & 2032
Table 4. Global Dental Anti-inflammatory Drugs Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Haleon Basic Information, Manufacturing Base and Competitors
Table 6. Haleon Major Business
Table 7. Haleon Dental Anti-inflammatory Drugs Product and Services
Table 8. Haleon Dental Anti-inflammatory Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. Haleon Recent Developments/Updates
Table 10. Taro Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 11. Taro Pharmaceuticals Major Business
Table 12. Taro Pharmaceuticals Dental Anti-inflammatory Drugs Product and Services
Table 13. Taro Pharmaceuticals Dental Anti-inflammatory Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. Taro Pharmaceuticals Recent Developments/Updates
Table 15. iNova Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 16. iNova Pharmaceuticals Major Business
Table 17. iNova Pharmaceuticals Dental Anti-inflammatory Drugs Product and Services
Table 18. iNova Pharmaceuticals Dental Anti-inflammatory Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. iNova Pharmaceuticals Recent Developments/Updates
Table 20. Lion Corporation Basic Information, Manufacturing Base and Competitors
Table 21. Lion Corporation Major Business
Table 22. Lion Corporation Dental Anti-inflammatory Drugs Product and Services
Table 23. Lion Corporation Dental Anti-inflammatory Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 24. Lion Corporation Recent Developments/Updates
Table 25. Sato Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 26. Sato Pharmaceutical Major Business
Table 27. Sato Pharmaceutical Dental Anti-inflammatory Drugs Product and Services
Table 28. Sato Pharmaceutical Dental Anti-inflammatory Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 29. Sato Pharmaceutical Recent Developments/Updates
Table 30. Daiichi Sankyo Healthcare Basic Information, Manufacturing Base and Competitors
Table 31. Daiichi Sankyo Healthcare Major Business
Table 32. Daiichi Sankyo Healthcare Dental Anti-inflammatory Drugs Product and Services
Table 33. Daiichi Sankyo Healthcare Dental Anti-inflammatory Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 34. Daiichi Sankyo Healthcare Recent Developments/Updates
Table 35. Rohto Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 36. Rohto Pharmaceutical Major Business
Table 37. Rohto Pharmaceutical Dental Anti-inflammatory Drugs Product and Services
Table 38. Rohto Pharmaceutical Dental Anti-inflammatory Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 39. Rohto Pharmaceutical Recent Developments/Updates
Table 40. Kobayashi Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 41. Kobayashi Pharmaceutical Major Business
Table 42. Kobayashi Pharmaceutical Dental Anti-inflammatory Drugs Product and Services
Table 43. Kobayashi Pharmaceutical Dental Anti-inflammatory Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 44. Kobayashi Pharmaceutical Recent Developments/Updates
Table 45. Kowa Company Basic Information, Manufacturing Base and Competitors
Table 46. Kowa Company Major Business
Table 47. Kowa Company Dental Anti-inflammatory Drugs Product and Services
Table 48. Kowa Company Dental Anti-inflammatory Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 49. Kowa Company Recent Developments/Updates
Table 50. Guilin Sanjin Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 51. Guilin Sanjin Pharmaceutical Major Business
Table 52. Guilin Sanjin Pharmaceutical Dental Anti-inflammatory Drugs Product and Services
Table 53. Guilin Sanjin Pharmaceutical Dental Anti-inflammatory Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 54. Guilin Sanjin Pharmaceutical Recent Developments/Updates
Table 55. ICPA Health Products Basic Information, Manufacturing Base and Competitors
Table 56. ICPA Health Products Major Business
Table 57. ICPA Health Products Dental Anti-inflammatory Drugs Product and Services
Table 58. ICPA Health Products Dental Anti-inflammatory Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 59. ICPA Health Products Recent Developments/Updates
Table 60. VistaPharm, Inc. Basic Information, Manufacturing Base and Competitors
Table 61. VistaPharm, Inc. Major Business
Table 62. VistaPharm, Inc. Dental Anti-inflammatory Drugs Product and Services
Table 63. VistaPharm, Inc. Dental Anti-inflammatory Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 64. VistaPharm, Inc. Recent Developments/Updates
Table 65. Patterson Dental Supply, Inc. Basic Information, Manufacturing Base and Competitors
Table 66. Patterson Dental Supply, Inc. Major Business
Table 67. Patterson Dental Supply, Inc. Dental Anti-inflammatory Drugs Product and Services
Table 68. Patterson Dental Supply, Inc. Dental Anti-inflammatory Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 69. Patterson Dental Supply, Inc. Recent Developments/Updates
Table 70. Global Dental Anti-inflammatory Drugs Sales Quantity by Manufacturer (2021-2026) & (K Units)
Table 71. Global Dental Anti-inflammatory Drugs Revenue by Manufacturer (2021-2026) & (USD Million)
Table 72. Global Dental Anti-inflammatory Drugs Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 73. Market Position of Manufacturers in Dental Anti-inflammatory Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 74. Head Office and Dental Anti-inflammatory Drugs Production Site of Key Manufacturer
Table 75. Dental Anti-inflammatory Drugs Market: Company Product Type Footprint
Table 76. Dental Anti-inflammatory Drugs Market: Company Product Application Footprint
Table 77. Dental Anti-inflammatory Drugs New Market Entrants and Barriers to Market Entry
Table 78. Dental Anti-inflammatory Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 79. Global Dental Anti-inflammatory Drugs Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 80. Global Dental Anti-inflammatory Drugs Sales Quantity by Region (2021-2026) & (K Units)
Table 81. Global Dental Anti-inflammatory Drugs Sales Quantity by Region (2027-2032) & (K Units)
Table 82. Global Dental Anti-inflammatory Drugs Consumption Value by Region (2021-2026) & (USD Million)
Table 83. Global Dental Anti-inflammatory Drugs Consumption Value by Region (2027-2032) & (USD Million)
Table 84. Global Dental Anti-inflammatory Drugs Average Price by Region (2021-2026) & (US$/Unit)
Table 85. Global Dental Anti-inflammatory Drugs Average Price by Region (2027-2032) & (US$/Unit)
Table 86. Global Dental Anti-inflammatory Drugs Sales Quantity by Type (2021-2026) & (K Units)
Table 87. Global Dental Anti-inflammatory Drugs Sales Quantity by Type (2027-2032) & (K Units)
Table 88. Global Dental Anti-inflammatory Drugs Consumption Value by Type (2021-2026) & (USD Million)
Table 89. Global Dental Anti-inflammatory Drugs Consumption Value by Type (2027-2032) & (USD Million)
Table 90. Global Dental Anti-inflammatory Drugs Average Price by Type (2021-2026) & (US$/Unit)
Table 91. Global Dental Anti-inflammatory Drugs Average Price by Type (2027-2032) & (US$/Unit)
Table 92. Global Dental Anti-inflammatory Drugs Sales Quantity by Application (2021-2026) & (K Units)
Table 93. Global Dental Anti-inflammatory Drugs Sales Quantity by Application (2027-2032) & (K Units)
Table 94. Global Dental Anti-inflammatory Drugs Consumption Value by Application (2021-2026) & (USD Million)
Table 95. Global Dental Anti-inflammatory Drugs Consumption Value by Application (2027-2032) & (USD Million)
Table 96. Global Dental Anti-inflammatory Drugs Average Price by Application (2021-2026) & (US$/Unit)
Table 97. Global Dental Anti-inflammatory Drugs Average Price by Application (2027-2032) & (US$/Unit)
Table 98. North America Dental Anti-inflammatory Drugs Sales Quantity by Type (2021-2026) & (K Units)
Table 99. North America Dental Anti-inflammatory Drugs Sales Quantity by Type (2027-2032) & (K Units)
Table 100. North America Dental Anti-inflammatory Drugs Sales Quantity by Application (2021-2026) & (K Units)
Table 101. North America Dental Anti-inflammatory Drugs Sales Quantity by Application (2027-2032) & (K Units)
Table 102. North America Dental Anti-inflammatory Drugs Sales Quantity by Country (2021-2026) & (K Units)
Table 103. North America Dental Anti-inflammatory Drugs Sales Quantity by Country (2027-2032) & (K Units)
Table 104. North America Dental Anti-inflammatory Drugs Consumption Value by Country (2021-2026) & (USD Million)
Table 105. North America Dental Anti-inflammatory Drugs Consumption Value by Country (2027-2032) & (USD Million)
Table 106. Europe Dental Anti-inflammatory Drugs Sales Quantity by Type (2021-2026) & (K Units)
Table 107. Europe Dental Anti-inflammatory Drugs Sales Quantity by Type (2027-2032) & (K Units)
Table 108. Europe Dental Anti-inflammatory Drugs Sales Quantity by Application (2021-2026) & (K Units)
Table 109. Europe Dental Anti-inflammatory Drugs Sales Quantity by Application (2027-2032) & (K Units)
Table 110. Europe Dental Anti-inflammatory Drugs Sales Quantity by Country (2021-2026) & (K Units)
Table 111. Europe Dental Anti-inflammatory Drugs Sales Quantity by Country (2027-2032) & (K Units)
Table 112. Europe Dental Anti-inflammatory Drugs Consumption Value by Country (2021-2026) & (USD Million)
Table 113. Europe Dental Anti-inflammatory Drugs Consumption Value by Country (2027-2032) & (USD Million)
Table 114. Asia-Pacific Dental Anti-inflammatory Drugs Sales Quantity by Type (2021-2026) & (K Units)
Table 115. Asia-Pacific Dental Anti-inflammatory Drugs Sales Quantity by Type (2027-2032) & (K Units)
Table 116. Asia-Pacific Dental Anti-inflammatory Drugs Sales Quantity by Application (2021-2026) & (K Units)
Table 117. Asia-Pacific Dental Anti-inflammatory Drugs Sales Quantity by Application (2027-2032) & (K Units)
Table 118. Asia-Pacific Dental Anti-inflammatory Drugs Sales Quantity by Region (2021-2026) & (K Units)
Table 119. Asia-Pacific Dental Anti-inflammatory Drugs Sales Quantity by Region (2027-2032) & (K Units)
Table 120. Asia-Pacific Dental Anti-inflammatory Drugs Consumption Value by Region (2021-2026) & (USD Million)
Table 121. Asia-Pacific Dental Anti-inflammatory Drugs Consumption Value by Region (2027-2032) & (USD Million)
Table 122. South America Dental Anti-inflammatory Drugs Sales Quantity by Type (2021-2026) & (K Units)
Table 123. South America Dental Anti-inflammatory Drugs Sales Quantity by Type (2027-2032) & (K Units)
Table 124. South America Dental Anti-inflammatory Drugs Sales Quantity by Application (2021-2026) & (K Units)
Table 125. South America Dental Anti-inflammatory Drugs Sales Quantity by Application (2027-2032) & (K Units)
Table 126. South America Dental Anti-inflammatory Drugs Sales Quantity by Country (2021-2026) & (K Units)
Table 127. South America Dental Anti-inflammatory Drugs Sales Quantity by Country (2027-2032) & (K Units)
Table 128. South America Dental Anti-inflammatory Drugs Consumption Value by Country (2021-2026) & (USD Million)
Table 129. South America Dental Anti-inflammatory Drugs Consumption Value by Country (2027-2032) & (USD Million)
Table 130. Middle East & Africa Dental Anti-inflammatory Drugs Sales Quantity by Type (2021-2026) & (K Units)
Table 131. Middle East & Africa Dental Anti-inflammatory Drugs Sales Quantity by Type (2027-2032) & (K Units)
Table 132. Middle East & Africa Dental Anti-inflammatory Drugs Sales Quantity by Application (2021-2026) & (K Units)
Table 133. Middle East & Africa Dental Anti-inflammatory Drugs Sales Quantity by Application (2027-2032) & (K Units)
Table 134. Middle East & Africa Dental Anti-inflammatory Drugs Sales Quantity by Country (2021-2026) & (K Units)
Table 135. Middle East & Africa Dental Anti-inflammatory Drugs Sales Quantity by Country (2027-2032) & (K Units)
Table 136. Middle East & Africa Dental Anti-inflammatory Drugs Consumption Value by Country (2021-2026) & (USD Million)
Table 137. Middle East & Africa Dental Anti-inflammatory Drugs Consumption Value by Country (2027-2032) & (USD Million)
Table 138. Dental Anti-inflammatory Drugs Raw Material
Table 139. Key Manufacturers of Dental Anti-inflammatory Drugs Raw Materials
Table 140. Dental Anti-inflammatory Drugs Typical Distributors
Table 141. Dental Anti-inflammatory Drugs Typical Customers
LIST OF FIGURES
Figure 1. Dental Anti-inflammatory Drugs Picture
Figure 2. Global Dental Anti-inflammatory Drugs Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Dental Anti-inflammatory Drugs Revenue Market Share by Type in 2025
Figure 4. Oral Rinse Examples
Figure 5. Oral Gel/Ointment Examples
Figure 6. Oral Spray Examples
Figure 7. Oral Tablets Examples
Figure 8. Oral Powder Examples
Figure 9. Others Examples
Figure 10. Global Dental Anti-inflammatory Drugs Revenue by Number of Active Ingredients, (USD Million), 2021 & 2025 & 2032
Figure 11. Global Dental Anti-inflammatory Drugs Revenue Market Share by Number of Active Ingredients in 2025
Figure 12. Single-Active-Ingredient Type (1 Active Ingredient) Examples
Figure 13. Multi-Active-Ingredient Type (≥2 Active Ingredients) Examples
Figure 14. Global Dental Anti-inflammatory Drugs Revenue by Pharmacological Action, (USD Million), 2021 & 2025 & 2032
Figure 15. Global Dental Anti-inflammatory Drugs Revenue Market Share by Pharmacological Action in 2025
Figure 16. Antimicrobial Examples
Figure 17. Anti-inflammatory Examples
Figure 18. Combined Antimicrobial and Anti-inflammatory Examples
Figure 19. Tissue Repair Examples
Figure 20. Others Examples
Figure 21. Global Dental Anti-inflammatory Drugs Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 22. Global Dental Anti-inflammatory Drugs Revenue Market Share by Application in 2025
Figure 23. Online Sales (Pharmaceutical E-Commerce Platforms, Online Hospital Marketplaces, Official Brand Stores, etc.) Examples
Figure 24. Hospitals (Dental Departments In General Hospitals, Specialized Dental Hospitals, Pediatric Dental Departments, etc.) Examples
Figure 25. Pharmacies (Chain Retail Pharmacies, Community Pharmacies, etc.) Examples
Figure 26. Clinics (Independent Dental Clinics, Dental Clinic Chains, etc.) Examples
Figure 27. Others Examples
Figure 28. Global Dental Anti-inflammatory Drugs Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 29. Global Dental Anti-inflammatory Drugs Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 30. Global Dental Anti-inflammatory Drugs Sales Quantity (2021-2032) & (K Units)
Figure 31. Global Dental Anti-inflammatory Drugs Price (2021-2032) & (US$/Unit)
Figure 32. Global Dental Anti-inflammatory Drugs Sales Quantity Market Share by Manufacturer in 2025
Figure 33. Global Dental Anti-inflammatory Drugs Revenue Market Share by Manufacturer in 2025
Figure 34. Producer Shipments of Dental Anti-inflammatory Drugs by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 35. Top 3 Dental Anti-inflammatory Drugs Manufacturer (Revenue) Market Share in 2025
Figure 36. Top 6 Dental Anti-inflammatory Drugs Manufacturer (Revenue) Market Share in 2025
Figure 37. Global Dental Anti-inflammatory Drugs Sales Quantity Market Share by Region (2021-2032)
Figure 38. Global Dental Anti-inflammatory Drugs Consumption Value Market Share by Region (2021-2032)
Figure 39. North America Dental Anti-inflammatory Drugs Consumption Value (2021-2032) & (USD Million)
Figure 40. Europe Dental Anti-inflammatory Drugs Consumption Value (2021-2032) & (USD Million)
Figure 41. Asia-Pacific Dental Anti-inflammatory Drugs Consumption Value (2021-2032) & (USD Million)
Figure 42. South America Dental Anti-inflammatory Drugs Consumption Value (2021-2032) & (USD Million)
Figure 43. Middle East & Africa Dental Anti-inflammatory Drugs Consumption Value (2021-2032) & (USD Million)
Figure 44. Global Dental Anti-inflammatory Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 45. Global Dental Anti-inflammatory Drugs Consumption Value Market Share by Type (2021-2032)
Figure 46. Global Dental Anti-inflammatory Drugs Average Price by Type (2021-2032) & (US$/Unit)
Figure 47. Global Dental Anti-inflammatory Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 48. Global Dental Anti-inflammatory Drugs Revenue Market Share by Application (2021-2032)
Figure 49. Global Dental Anti-inflammatory Drugs Average Price by Application (2021-2032) & (US$/Unit)
Figure 50. North America Dental Anti-inflammatory Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 51. North America Dental Anti-inflammatory Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 52. North America Dental Anti-inflammatory Drugs Sales Quantity Market Share by Country (2021-2032)
Figure 53. North America Dental Anti-inflammatory Drugs Consumption Value Market Share by Country (2021-2032)
Figure 54. United States Dental Anti-inflammatory Drugs Consumption Value (2021-2032) & (USD Million)
Figure 55. Canada Dental Anti-inflammatory Drugs Consumption Value (2021-2032) & (USD Million)
Figure 56. Mexico Dental Anti-inflammatory Drugs Consumption Value (2021-2032) & (USD Million)
Figure 57. Europe Dental Anti-inflammatory Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 58. Europe Dental Anti-inflammatory Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 59. Europe Dental Anti-inflammatory Drugs Sales Quantity Market Share by Country (2021-2032)
Figure 60. Europe Dental Anti-inflammatory Drugs Consumption Value Market Share by Country (2021-2032)
Figure 61. Germany Dental Anti-inflammatory Drugs Consumption Value (2021-2032) & (USD Million)
Figure 62. France Dental Anti-inflammatory Drugs Consumption Value (2021-2032) & (USD Million)
Figure 63. United Kingdom Dental Anti-inflammatory Drugs Consumption Value (2021-2032) & (USD Million)
Figure 64. Russia Dental Anti-inflammatory Drugs Consumption Value (2021-2032) & (USD Million)
Figure 65. Italy Dental Anti-inflammatory Drugs Consumption Value (2021-2032) & (USD Million)
Figure 66. Asia-Pacific Dental Anti-inflammatory Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 67. Asia-Pacific Dental Anti-inflammatory Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 68. Asia-Pacific Dental Anti-inflammatory Drugs Sales Quantity Market Share by Region (2021-2032)
Figure 69. Asia-Pacific Dental Anti-inflammatory Drugs Consumption Value Market Share by Region (2021-2032)
Figure 70. China Dental Anti-inflammatory Drugs Consumption Value (2021-2032) & (USD Million)
Figure 71. Japan Dental Anti-inflammatory Drugs Consumption Value (2021-2032) & (USD Million)
Figure 72. South Korea Dental Anti-inflammatory Drugs Consumption Value (2021-2032) & (USD Million)
Figure 73. India Dental Anti-inflammatory Drugs Consumption Value (2021-2032) & (USD Million)
Figure 74. Southeast Asia Dental Anti-inflammatory Drugs Consumption Value (2021-2032) & (USD Million)
Figure 75. Australia Dental Anti-inflammatory Drugs Consumption Value (2021-2032) & (USD Million)
Figure 76. South America Dental Anti-inflammatory Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 77. South America Dental Anti-inflammatory Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 78. South America Dental Anti-inflammatory Drugs Sales Quantity Market Share by Country (2021-2032)
Figure 79. South America Dental Anti-inflammatory Drugs Consumption Value Market Share by Country (2021-2032)
Figure 80. Brazil Dental Anti-inflammatory Drugs Consumption Value (2021-2032) & (USD Million)
Figure 81. Argentina Dental Anti-inflammatory Drugs Consumption Value (2021-2032) & (USD Million)
Figure 82. Middle East & Africa Dental Anti-inflammatory Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 83. Middle East & Africa Dental Anti-inflammatory Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 84. Middle East & Africa Dental Anti-inflammatory Drugs Sales Quantity Market Share by Country (2021-2032)
Figure 85. Middle East & Africa Dental Anti-inflammatory Drugs Consumption Value Market Share by Country (2021-2032)
Figure 86. Turkey Dental Anti-inflammatory Drugs Consumption Value (2021-2032) & (USD Million)
Figure 87. Egypt Dental Anti-inflammatory Drugs Consumption Value (2021-2032) & (USD Million)
Figure 88. Saudi Arabia Dental Anti-inflammatory Drugs Consumption Value (2021-2032) & (USD Million)
Figure 89. South Africa Dental Anti-inflammatory Drugs Consumption Value (2021-2032) & (USD Million)
Figure 90. Dental Anti-inflammatory Drugs Market Drivers
Figure 91. Dental Anti-inflammatory Drugs Market Restraints
Figure 92. Dental Anti-inflammatory Drugs Market Trends
Figure 93. Porters Five Forces Analysis
Figure 94. Manufacturing Cost Structure Analysis of Dental Anti-inflammatory Drugs in 2025
Figure 95. Manufacturing Process Analysis of Dental Anti-inflammatory Drugs
Figure 96. Dental Anti-inflammatory Drugs Industrial Chain
Figure 97. Sales Channel: Direct to End-User vs Distributors
Figure 98. Direct Channel Pros & Cons
Figure 99. Indirect Channel Pros & Cons
Figure 100. Methodology
Figure 101. Research Process and Data Source
Figure 1. Dental Anti-inflammatory Drugs Picture
Figure 2. Global Dental Anti-inflammatory Drugs Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Dental Anti-inflammatory Drugs Revenue Market Share by Type in 2025
Figure 4. Oral Rinse Examples
Figure 5. Oral Gel/Ointment Examples
Figure 6. Oral Spray Examples
Figure 7. Oral Tablets Examples
Figure 8. Oral Powder Examples
Figure 9. Others Examples
Figure 10. Global Dental Anti-inflammatory Drugs Revenue by Number of Active Ingredients, (USD Million), 2021 & 2025 & 2032
Figure 11. Global Dental Anti-inflammatory Drugs Revenue Market Share by Number of Active Ingredients in 2025
Figure 12. Single-Active-Ingredient Type (1 Active Ingredient) Examples
Figure 13. Multi-Active-Ingredient Type (≥2 Active Ingredients) Examples
Figure 14. Global Dental Anti-inflammatory Drugs Revenue by Pharmacological Action, (USD Million), 2021 & 2025 & 2032
Figure 15. Global Dental Anti-inflammatory Drugs Revenue Market Share by Pharmacological Action in 2025
Figure 16. Antimicrobial Examples
Figure 17. Anti-inflammatory Examples
Figure 18. Combined Antimicrobial and Anti-inflammatory Examples
Figure 19. Tissue Repair Examples
Figure 20. Others Examples
Figure 21. Global Dental Anti-inflammatory Drugs Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 22. Global Dental Anti-inflammatory Drugs Revenue Market Share by Application in 2025
Figure 23. Online Sales (Pharmaceutical E-Commerce Platforms, Online Hospital Marketplaces, Official Brand Stores, etc.) Examples
Figure 24. Hospitals (Dental Departments In General Hospitals, Specialized Dental Hospitals, Pediatric Dental Departments, etc.) Examples
Figure 25. Pharmacies (Chain Retail Pharmacies, Community Pharmacies, etc.) Examples
Figure 26. Clinics (Independent Dental Clinics, Dental Clinic Chains, etc.) Examples
Figure 27. Others Examples
Figure 28. Global Dental Anti-inflammatory Drugs Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 29. Global Dental Anti-inflammatory Drugs Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 30. Global Dental Anti-inflammatory Drugs Sales Quantity (2021-2032) & (K Units)
Figure 31. Global Dental Anti-inflammatory Drugs Price (2021-2032) & (US$/Unit)
Figure 32. Global Dental Anti-inflammatory Drugs Sales Quantity Market Share by Manufacturer in 2025
Figure 33. Global Dental Anti-inflammatory Drugs Revenue Market Share by Manufacturer in 2025
Figure 34. Producer Shipments of Dental Anti-inflammatory Drugs by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 35. Top 3 Dental Anti-inflammatory Drugs Manufacturer (Revenue) Market Share in 2025
Figure 36. Top 6 Dental Anti-inflammatory Drugs Manufacturer (Revenue) Market Share in 2025
Figure 37. Global Dental Anti-inflammatory Drugs Sales Quantity Market Share by Region (2021-2032)
Figure 38. Global Dental Anti-inflammatory Drugs Consumption Value Market Share by Region (2021-2032)
Figure 39. North America Dental Anti-inflammatory Drugs Consumption Value (2021-2032) & (USD Million)
Figure 40. Europe Dental Anti-inflammatory Drugs Consumption Value (2021-2032) & (USD Million)
Figure 41. Asia-Pacific Dental Anti-inflammatory Drugs Consumption Value (2021-2032) & (USD Million)
Figure 42. South America Dental Anti-inflammatory Drugs Consumption Value (2021-2032) & (USD Million)
Figure 43. Middle East & Africa Dental Anti-inflammatory Drugs Consumption Value (2021-2032) & (USD Million)
Figure 44. Global Dental Anti-inflammatory Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 45. Global Dental Anti-inflammatory Drugs Consumption Value Market Share by Type (2021-2032)
Figure 46. Global Dental Anti-inflammatory Drugs Average Price by Type (2021-2032) & (US$/Unit)
Figure 47. Global Dental Anti-inflammatory Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 48. Global Dental Anti-inflammatory Drugs Revenue Market Share by Application (2021-2032)
Figure 49. Global Dental Anti-inflammatory Drugs Average Price by Application (2021-2032) & (US$/Unit)
Figure 50. North America Dental Anti-inflammatory Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 51. North America Dental Anti-inflammatory Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 52. North America Dental Anti-inflammatory Drugs Sales Quantity Market Share by Country (2021-2032)
Figure 53. North America Dental Anti-inflammatory Drugs Consumption Value Market Share by Country (2021-2032)
Figure 54. United States Dental Anti-inflammatory Drugs Consumption Value (2021-2032) & (USD Million)
Figure 55. Canada Dental Anti-inflammatory Drugs Consumption Value (2021-2032) & (USD Million)
Figure 56. Mexico Dental Anti-inflammatory Drugs Consumption Value (2021-2032) & (USD Million)
Figure 57. Europe Dental Anti-inflammatory Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 58. Europe Dental Anti-inflammatory Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 59. Europe Dental Anti-inflammatory Drugs Sales Quantity Market Share by Country (2021-2032)
Figure 60. Europe Dental Anti-inflammatory Drugs Consumption Value Market Share by Country (2021-2032)
Figure 61. Germany Dental Anti-inflammatory Drugs Consumption Value (2021-2032) & (USD Million)
Figure 62. France Dental Anti-inflammatory Drugs Consumption Value (2021-2032) & (USD Million)
Figure 63. United Kingdom Dental Anti-inflammatory Drugs Consumption Value (2021-2032) & (USD Million)
Figure 64. Russia Dental Anti-inflammatory Drugs Consumption Value (2021-2032) & (USD Million)
Figure 65. Italy Dental Anti-inflammatory Drugs Consumption Value (2021-2032) & (USD Million)
Figure 66. Asia-Pacific Dental Anti-inflammatory Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 67. Asia-Pacific Dental Anti-inflammatory Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 68. Asia-Pacific Dental Anti-inflammatory Drugs Sales Quantity Market Share by Region (2021-2032)
Figure 69. Asia-Pacific Dental Anti-inflammatory Drugs Consumption Value Market Share by Region (2021-2032)
Figure 70. China Dental Anti-inflammatory Drugs Consumption Value (2021-2032) & (USD Million)
Figure 71. Japan Dental Anti-inflammatory Drugs Consumption Value (2021-2032) & (USD Million)
Figure 72. South Korea Dental Anti-inflammatory Drugs Consumption Value (2021-2032) & (USD Million)
Figure 73. India Dental Anti-inflammatory Drugs Consumption Value (2021-2032) & (USD Million)
Figure 74. Southeast Asia Dental Anti-inflammatory Drugs Consumption Value (2021-2032) & (USD Million)
Figure 75. Australia Dental Anti-inflammatory Drugs Consumption Value (2021-2032) & (USD Million)
Figure 76. South America Dental Anti-inflammatory Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 77. South America Dental Anti-inflammatory Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 78. South America Dental Anti-inflammatory Drugs Sales Quantity Market Share by Country (2021-2032)
Figure 79. South America Dental Anti-inflammatory Drugs Consumption Value Market Share by Country (2021-2032)
Figure 80. Brazil Dental Anti-inflammatory Drugs Consumption Value (2021-2032) & (USD Million)
Figure 81. Argentina Dental Anti-inflammatory Drugs Consumption Value (2021-2032) & (USD Million)
Figure 82. Middle East & Africa Dental Anti-inflammatory Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 83. Middle East & Africa Dental Anti-inflammatory Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 84. Middle East & Africa Dental Anti-inflammatory Drugs Sales Quantity Market Share by Country (2021-2032)
Figure 85. Middle East & Africa Dental Anti-inflammatory Drugs Consumption Value Market Share by Country (2021-2032)
Figure 86. Turkey Dental Anti-inflammatory Drugs Consumption Value (2021-2032) & (USD Million)
Figure 87. Egypt Dental Anti-inflammatory Drugs Consumption Value (2021-2032) & (USD Million)
Figure 88. Saudi Arabia Dental Anti-inflammatory Drugs Consumption Value (2021-2032) & (USD Million)
Figure 89. South Africa Dental Anti-inflammatory Drugs Consumption Value (2021-2032) & (USD Million)
Figure 90. Dental Anti-inflammatory Drugs Market Drivers
Figure 91. Dental Anti-inflammatory Drugs Market Restraints
Figure 92. Dental Anti-inflammatory Drugs Market Trends
Figure 93. Porters Five Forces Analysis
Figure 94. Manufacturing Cost Structure Analysis of Dental Anti-inflammatory Drugs in 2025
Figure 95. Manufacturing Process Analysis of Dental Anti-inflammatory Drugs
Figure 96. Dental Anti-inflammatory Drugs Industrial Chain
Figure 97. Sales Channel: Direct to End-User vs Distributors
Figure 98. Direct Channel Pros & Cons
Figure 99. Indirect Channel Pros & Cons
Figure 100. Methodology
Figure 101. Research Process and Data Source
